We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+2.17%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$15.4B
AUM Growth
+$794M
Cap. Flow
+$588M
Cap. Flow %
3.81%
Top 10 Hldgs %
11.65%
Holding
3,018
New
218
Increased
954
Reduced
767
Closed
228

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$67.6M
2
SBUX icon
Starbucks
SBUX
+$63.1M
3
HLT icon
Hilton Worldwide
HLT
+$44.5M
4
META icon
Meta Platforms (Facebook)
META
+$44.3M
5
HOG icon
Harley-Davidson
HOG
+$43.2M

Sector Composition

Rank Sector Weight
1 Technology 15.53%
2 Healthcare 14.16%
3 Financials 11.14%
4 Industrials 10.83%
5 Consumer Discretionary 10.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACET
601
DELISTED
Aceto Corp
ACET
$1.57M 0.01%
66,865
+27,961
+72% +$618K
UNM icon
602
Unum
UNM
$13.8B
$1.56M 0.01%
50,604
+7,585
+18% +$223K
IJJ icon
603
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.85B
$1.53M 0.01%
24,742
OII icon
604
Oceaneering
OII
$5.25B
$1.53M 0.01%
46,034
-1,885
-4% -$58.7K
UHS icon
605
Universal Health Services
UHS
$9.43B
$1.51M 0.01%
12,149
+10
+0.1% +$1.13K
PNW icon
606
Pinnacle West Capital
PNW
$12.9B
$1.48M 0.01%
19,710
+35
+0.2% +$2.39K
SVC
607
Service Properties Trust
SVC
$1.1B
$1.47M 0.01%
11,100
-18,282
-62% -$2.22M
ENH
608
DELISTED
Endurance Specialty Holdings Ltd
ENH
$1.45M 0.01%
22,220
-9,420
-30% -$589K
HEP
609
DELISTED
Holly Energy Partners, L.P.
HEP
$1.44M 0.01%
+42,709
New +$1.21M
A icon
610
Agilent Technologies
A
$39.1B
$1.44M 0.01%
36,085
+222
+0.6% +$8.46K
ENLK
611
DELISTED
EnLink Midstream Partners, LP
ENLK
$1.41M 0.01%
117,000
-12,697
-10% -$139K
ALB icon
612
Albemarle
ALB
$13.5B
$1.41M 0.01%
22,085
-270
-1% -$14.8K
DOC icon
613
Healthpeak Properties
DOC
$15.4B
$1.41M 0.01%
47,472
+470
+1% +$14.1K
HBI
614
DELISTED
Hanesbrands
HBI
$1.4M 0.01%
49,499
+71
+0.1% +$2.03K
SWBI icon
615
Smith & Wesson
SWBI
$655M
$1.4M 0.01%
68,429
-33,117
-33% -$616K
PCAR icon
616
PACCAR
PCAR
$69.6B
$1.39M 0.01%
38,175
-119,999
-76% -$4.02M
BMRN icon
617
BioMarin Pharmaceuticals
BMRN
$11.5B
$1.36M 0.01%
16,525
-350
-2% -$28.5K
VA
618
DELISTED
Virgin America Inc.
VA
$1.35M 0.01%
+35,100
New +$1.09M
WFC.PRJ.CL
619
DELISTED
Wells Fargo & Company
WFC.PRJ.CL
$1.31M 0.01%
46,774
CF icon
620
CF Industries
CF
$19.2B
$1.3M 0.01%
41,506
+18,021
+77% +$588K
EXPD icon
621
Expeditors International
EXPD
$22.9B
$1.3M 0.01%
26,555
-489,988
-95% -$22.5M
ACOR
622
DELISTED
Acorda Therapeutics
ACOR
$1.29M 0.01%
408
+1
+0.2% +$4.15K
XLB icon
623
State Street Materials Select Sector SPDR ETF
XLB
$8.51B
$1.29M 0.01%
57,648
-1,780
-3% -$36.9K
MIDD icon
624
Middleby
MIDD
$6.05B
$1.29M 0.01%
12,086
-19
-0.2% -$1.79K
EQT icon
625
EQT Corp
EQT
$33.2B
$1.28M 0.01%
35,066
-383
-1% -$12.3K

Similar funds

Glenmede Trust's Q1 2016 Portfolio in Review

As of Q1 2016, Glenmede Trust held 3,018 positions worth $15.4B, up 5.4% from $14.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Glenmede Trust deployed $588M of net new capital in Q1 2016, opening 218 new positions and adding to 954 existing holdings. Its largest new stake was Vanguard FTSE Developed Markets ETF: 723,506 shares worth $26M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Activision Blizzard, an estimated $50.7M trimmed.

  • Glenmede Trust's largest Q1 2016 buy was Vanguard FTSE Developed Markets ETF: 723,506 shares worth $26M.
  • Glenmede Trust added most to Oracle in Q1 2016, an estimated $67.6M increase.
  • Glenmede Trust's biggest Q1 2016 reduction was Activision Blizzard, cutting an estimated $50.7M.
  • Glenmede Trust fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $50M.
  • Glenmede Trust's ten largest holdings make up 12% of its $15.4B portfolio in Q1 2016.
  • Glenmede Trust opened 218 new positions and closed 228 in Q1 2016.
  • Glenmede Trust's portfolio value rose 5.4% quarter-over-quarter to $15.4B.

Based on Glenmede Trust's 13F filing for Q1 2016, filed 26 Apr 2016.